Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HERPUD2 antisense RNA 1 (HERPUD2-AS1) is a primate-specific long non-coding RNA (lncRNA) classified as an antisense transcript located at chromosome 7p14.2, overlapping with HERPUD2[3][1]. As an lncRNA, it is not translated into protein but exerts regulatory functions at the RNA level, potentially through regulation of gene expression, transcriptional modulation, or epigenetic mechanisms[1][7][9]. HERPUD2-AS1 is considered a highly specific neuronal marker and may be involved in the regulation of endoplasmic reticulum (ER) stress pathways[1]. There is growing interest in lncRNAs like HERPUD2-AS1 due to their putative contributions to disease processes such as cancer, neurodegenerative disorders, and autoimmunity, but direct functional or therapeutic targeting information for HERPUD2-AS1 is currently lacking; its precise biological functions and disease associations remain to be fully characterized[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HERPUD2 antisense RNA 1 (HERPUD2-AS1).